Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients
Autoři | |
---|---|
Rok publikování | 2022 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Cancers |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.mdpi.com/2072-6694/14/7/1699 |
Doi | http://dx.doi.org/10.3390/cancers14071699 |
Klíčová slova | hypolipidemic agents; statins; second primary malignancies; second primary cancers; multiple primary neoplasms; colorectal cancer; cancer survivors |